Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.

Ocular inflammatory reactions have been described in patients on bisphosphonate treatment. We estimated the incidence rate of ocular inflammation at 3 and 12 months in patients treated for osteoporosis using a register-based cohort linked to prescription data (hospitals and private practice) and hos...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Pazianas, M, Clark, E, Eiken, P, Brixen, K, Abrahamsen, B
Format:	Journal article
Sprog:	English
Udgivet:	2013

Lignende værker

Safety issues with bisphosphonate therapy for osteoporosis.
af: Suresh, E, et al.
Udgivet: (2014)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
af: Pazianas, M, et al.
Udgivet: (2012)

Bisphosphonates and colon cancer: reply.
af: Pazianas, M, et al.
Udgivet: (2013)

Bisphosphonates and colon cancer: Reply
af: Pazianas, M, et al.
Udgivet: (2013)

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
af: Pazianas, M, et al.
Udgivet: (2014)

Safety of bisphosphonates.
af: Pazianas, M, et al.
Udgivet: (2011)

The art of treating osteoporosis: Bisphosphonates
af: Sergey Olegovich Mazurenko
Udgivet: (2012-03-01)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
af: Pazianas, M, et al.
Udgivet: (2010)

Eliminating the need for fasting with oral administration of bisphosphonates.
af: Pazianas, M, et al.
Udgivet: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates
af: Pazianas M, et al.
Udgivet: (2013-10-01)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
af: Pazianas, M, et al.
Udgivet: (2012)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
af: Abrahamsen, B, et al.
Udgivet: (2013)

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
af: Pazianas, M, et al.
Udgivet: (2007)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
af: Luca Dalle Carbonare, et al.
Udgivet: (2010-08-01)

The use of bisphosphonates to treat osteoporosis in patients with Lysinuric Protein Intolerance
af: Jos Draaisma, et al.
Udgivet: (2021-04-01)

Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
af: Francisco Bandeira, et al.
Udgivet: (2020-07-01)

The risk of oesophageal and gastric cancer incidence and mortality in alendronate users: National cohort study
af: Abrahamsen, B, et al.
Udgivet: (2011)

Intravenous bisphosphonates for postmenopausal osteoporosis
af: Peyman Mottaghi
Udgivet: (2010-01-01)

Intravenous Bisphosphonates for Postmenopausal Osteoporosis
af: Peyman Mottaghi
Udgivet: (2010-01-01)

Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
af: Jiaqi Wu, et al.
Udgivet: (2018-08-01)

Evaluating the antifracture efficacy of bisphosphonates.
af: Pazianas, M, et al.
Udgivet: (2009)

Bisphosphonates and bone quality.
af: Pazianas, M, et al.
Udgivet: (2014)

Atrial fibrillation and bisphosphonate therapy.
af: Pazianas, M, et al.
Udgivet: (2010)

A reappraisal of generic bisphosphonates in osteoporosis.
af: Kanis, J, et al.
Udgivet: (2012)

The use of bisphosphonates for the treatment and prevention of osteoporosis
af: O. A. Nikitinskaya, et al.
Udgivet: (2022-08-01)

Bone Quality and Fractures in Women With Osteoporosis Treated With Bisphosphonates for 1 to 14 Years
af: Hartmut H Malluche, et al.
Udgivet: (2021-11-01)

Potential therapeutic effects of oral bisphosphonates on the intestine.
af: Pazianas, M, et al.
Udgivet: (2011)

Prevention and treatment of osteoporosis in inflammatory bowel disease.
af: Lichtenstein, G, et al.
Udgivet: (2006)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
af: Yilin Zhu, et al.
Udgivet: (2020-05-01)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
af: Pazianas, M
Udgivet: (2013)

NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
af: Michael Pazianas
Udgivet: (2021-08-01)

Long-term consequences of osteoporosis therapy with bisphosphonates
af: Bárbara Gehrke, et al.
Udgivet: (2023-11-01)

Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases.
af: Boonen, S, et al.
Udgivet: (2009)

Atrial fibrillation and the use of oral bisphosphonates
af: Michael Pazianas, et al.
Udgivet: (2011-03-01)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
af: Zaoqian Zheng, et al.
Udgivet: (2020-09-01)

glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
af: Natalia Vladimirovna Toroptsova, et al.
Udgivet: (2013-12-01)

Safety and efficacy of bisphosphonates in thalassemia patients with osteopenia/osteoporosis
af: Sujata Sharma, et al.
Udgivet: (2023-04-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
af: İlke Coşkun Benlidayı, et al.
Udgivet: (2015-08-01)

Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates
af: Gu T, et al.
Udgivet: (2016-02-01)

glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
af: Natalia Vladimirovna Toroptsova, et al.
Udgivet: (2013-12-01)